No document available.
Keywords :
Alanine; Amino Acid Sequence; Base Sequence; Cell Division/drug effects; Growth Hormone/genetics; Humans; Lymphoma; Molecular Sequence Data; *Mutagenesis, Site-Directed; Prolactin/chemistry/*genetics/pharmacology; Protein Structure, Secondary; Receptors, Prolactin/metabolism; Regulatory Sequences, Nucleic Acid; Sequence Alignment; Sequence Homology; Tumor Cells, Cultured
Abstract :
[en] We have generated 10 alanine mutants of human PRL (hPRL), a member of the PRL/GH family, to investigate the involvement of the highly conserved 58-74 region in the biological behavior of the protein. When treated with polyclonal anti-hPRL antibodies, all mutants were immunologically indistinguishable from the unmodified hPRL, and circular dichroism analyses indicated that their alpha-helix content was similar to that of the unmodified hormone. Mutations C58A, K69A, and, to a lesser extent, P66A affected drastically the ability of hPRL first to bind to the lactogenic receptor and second to stimulate the proliferation of Nb2 lymphoma cells, proving the importance of the 58-74 peptide segment for hPRL bioactivity. Binding affinities of these mutants to the Nb2 lactogenic receptor have been compared to lactogenic binding data previously obtained for several mutants of hGH. The comparison reveals that the residues involved in the biological properties of the two proteins are not at topologically equivalent positions. Hence, we suggest that the binding of these hormones to the lactogenic receptors occurs through a different molecular mechanism having distinct requirements at the residue level.
Scopus citations®
without self-citations
36